CFD-d on keerulised instrumendid, millega kaasneb võimenduse tõttu suur risk kiiresti raha kaotada. 84% jaeinvestoritest kaotab selle pakkuja juures CFD-dega kaubeldes raha. Mõelge järele, kas mõistate CFD-de toimimise põhimõtet ja kas saate endale lubada riski rahast ilma jääda.

Scan to Download iOS&Android APP

Ost-müük Eli Lilly & Co - LLY CFD

337.93
2.28%
2.49
Madal: 329.73
Kõrge: 341.12
Market Trading Hours* (UTC) Opens on Monday at 14:30

Mon - Fri: 14:30 - 21:00

  • Kokkuvõte
  • Ajaloolised andmed
  • Sündmused
  • Tuluaruanne
  • Bilanss
  • Rahavood
  • Omand
Kauplemistingimused
Hinnavahe 2.49
Pika positsiooni ööpäeva tasu

Long position overnight fee


Margin. Your investment $1,000.00
Üleöö tasu -0.030779 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Mine platvormile
-0.030779%
Lühikese positsiooni ööpäeva tasu

Short position overnight fee


Margin. Your investment $1,000.00
Üleöö tasu -0.013666 %
Charges from borrowed part ($-0.55)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Mine platvormile
-0.013666%
Ööpäeva tasu aeg 22:00 (UTC)
Min kauplemise kogus 1
Valuuta USD
Tagatis 20%
Aktsiabörs United States of America
Kauplemise vahendustasu 0%

*Information provided by Capital.com

Eli Lilly and Co ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

Võtmestatistika
Eelmine sulgemine* 330.39
Avatud* 329.73
Aastane muutus* 31.38%
Päeva ulatus* 329.73 - 341.12
52 nädala ulatus 231.87-384.44
Keskmine maht (10 päeva) 3.98M
Keskmine maht (3 kuud) 59.59M
Turukapitalisatsioon 322.19B
P/E suhtarv 49.13
Ringluses olevad aktsiad 950.18M
Tulu 28.54B
EPS 6.90
Dividendid (% kasumist) 1.33302
Beeta 0.33
Järgmine tuluaruande kuupäev Apr 27, 2023

Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Sulgemishind Change (%) Avamishind High Low
Feb 3, 2023 337.93 5.58 1.68% 332.35 342.09 328.30
Feb 2, 2023 330.39 -2.41 -0.72% 332.80 334.80 316.14
Feb 1, 2023 342.15 1.23 0.36% 340.92 345.40 336.80
Jan 31, 2023 343.91 5.17 1.53% 338.74 344.11 338.74
Jan 30, 2023 340.18 -1.86 -0.54% 342.04 347.28 339.15
Jan 27, 2023 341.77 -2.99 -0.87% 344.76 347.70 341.32
Jan 26, 2023 347.65 -2.14 -0.61% 349.79 351.79 346.30
Jan 25, 2023 349.26 7.35 2.15% 341.91 349.50 341.91
Jan 24, 2023 345.92 -16.82 -4.64% 362.74 364.89 339.80
Jan 23, 2023 341.82 -2.04 -0.59% 343.86 345.86 339.80
Jan 20, 2023 345.80 1.01 0.29% 344.79 348.73 341.12
Jan 19, 2023 350.82 1.39 0.40% 349.43 355.30 349.43
Jan 18, 2023 351.45 -4.05 -1.14% 355.50 358.73 351.25
Jan 17, 2023 357.38 -1.09 -0.30% 358.47 361.50 356.17
Jan 13, 2023 361.23 6.08 1.71% 355.15 362.95 355.15
Jan 12, 2023 358.72 3.25 0.91% 355.47 360.15 351.69
Jan 11, 2023 359.86 7.67 2.18% 352.19 361.49 348.71
Jan 10, 2023 352.54 5.75 1.66% 346.79 352.96 342.22
Jan 9, 2023 349.45 -13.34 -3.68% 362.79 364.60 348.43
Jan 6, 2023 362.71 4.92 1.38% 357.79 366.20 356.41

Eli Lilly & Co Events

Time (UTC) Country Event
No events scheduled
View all events
  • Aastas
  • Kvartalis
2016 2017 2018 2019 2020 2021
Kogutulu 21222.1 19973.8 21493.3 22319.5 24539.8 28318.4
Tulu 21222.1 19973.8 21493.3 22319.5 24539.8 28318.4
Kulud, Kokku 5654.9 4447.7 4681.7 4721.2 5483.3 7312.8
Brutokasum 15567.2 15526.1 16811.6 17598.3 19056.5 21005.6
Kogu tegevuskulu 17763.3 17970.5 17958.8 17287.9 18481.8 22366.5
Müük/Üldine/admin kulud, kokku 6452 5982.4 5975.1 6213.8 6121.2 6431.6
Uuringud ja arendus 5243.9 5096.2 5051.2 5595 6085.7 7025.9
Ootamatud kulutused (tulu) 412.5 2444.2 2250.8 757.9 791.6 1596.2
Tulud majandustegevusest 3458.8 2003.3 3534.5 5031.6 6058 5951.9
Intressitulud (kulu), muud tulud, neto -76.5 -58.6 -83.2 -320.2 -326.6 -137.5
Muud, neto -8.3 360.1 228.8 554.5 1498.5 341.1
Netotulu enne makse 3374 2304.8 3680.1 5265.9 7229.9 6155.5
Netotulu pärast makse 2737.6 4493.6 3325.9 4637.9 6193.7 5581.7
Netotulu enne erikulusid 2737.6 4493.6 3325.9 4637.9 6193.7 5581.7
Netotulu 2737.6 -204.1 3232 8318.4 6193.7 5581.7
Arvestatav tulu, v a erikulud 2737.6 4493.6 3325.9 4637.9 6193.7 5581.7
Arvestatav tulu, koos erikuludega 2737.6 -204.1 3232 8318.4 6193.7 5581.7
Jaotamisele kuuluv netotulu 2737.6 -204.1 3232 8318.4 6193.7 5581.7
Keskmine jaotamisele kuuluv aktsia kohta 1061.82 1052.02 1033.67 935.684 912.505 911.681
Jaotatav EPS, v a erakorralised kulud 2.5782 4.27139 3.21757 4.95669 6.78758 6.12243
Dividends per Share - Common Stock Primary Issue 2.04 2.08 2.25 2.58 2.96 3.4
Jaotamisele kuuluv normaal-EPS 2.89874 6.15171 5.37021 5.70063 7.63447 7.79951
Erakorralised kulud kokku -4697.7 -93.9 3680.5 0 0
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Kogutulu 6805.6 6740.1 6772.8 7999.9 7810
Tulu 6805.6 6740.1 6772.8 7999.9 7810
Kulud, Kokku 1878.6 1953.2 1430.8 2050.2 2072.1
Brutokasum 4927 4786.9 5342 5949.7 5737.9
Kogu tegevuskulu 5650.3 5336.7 5296.8 6082.7 5405.7
Müük/Üldine/admin kulud, kokku 1576 1685.7 1577.9 1592 1557.9
Uuringud ja arendus 1684.8 1672.8 1708.9 1959.4 1610.1
Ootamatud kulutused (tulu) 510.9 25 579.2 481.1 165.6
Tulud majandustegevusest 1155.3 1403.4 1476 1917.2 2404.3
Intressitulud (kulu), muud tulud, neto 219.2 133.9 -323.4 -167.2 -503.3
Muud, neto 101.9 56.6 92.7 89.9 152.6
Netotulu enne makse 1476.4 1593.9 1245.3 1839.9 2053.6
Netotulu pärast makse 1355.3 1390.2 1110.1 1726.1 1902.9
Netotulu enne erikulusid 1355.3 1390.2 1110.1 1726.1 1902.9
Netotulu 1355.3 1390.2 1110.1 1726.1 1902.9
Arvestatav tulu, v a erikulud 1355.3 1390.2 1110.1 1726.1 1902.9
Arvestatav tulu, koos erikuludega 1355.3 1390.2 1110.1 1726.1 1902.9
Jaotamisele kuuluv netotulu 1355.3 1390.2 1110.1 1726.1 1902.9
Keskmine jaotamisele kuuluv aktsia kohta 912.4 910.4 910.8 911.624 906.4
Jaotatav EPS, v a erakorralised kulud 1.48542 1.52702 1.21882 1.89343 2.0994
Dividends per Share - Common Stock Primary Issue 0.85 0.85 0.85 0.85 0.98
Jaotamisele kuuluv normaal-EPS 2.02635 1.55448 1.80644 2.41408 2.28211
Erakorralised kulud kokku 0
  • Aastas
  • Kvartalis
2016 2017 2018 2019 2020 2021
Käibevarad kokku 15101.4 19202.1 20549.6 13709.6 17462.1 18452.4
Raha ja lühiajalised investeeringud 6038.6 8034.1 7408.9 2438.5 3681.3 3908.6
Raha ja ekvivalendid 4582.1 6536.2 7320.7 2337.5 3657.1 3818.5
Lühiajalised investeeringud 1456.5 1497.9 88.2 101 24.2 90.1
Laekumata arved, neto 4766.3 5262.2 5776.8 5541.5 6929 8127.2
Accounts Receivable - Trade, Net 4029.4 4546.3 5776.8 4547.3 5875.3 6672.8
Total Inventory 3561.9 4458.3 3098.1 3190.7 3980.3 3886
Prepaid Expenses 734.6 1447.5 2036.7 2538.9 2871.5 2530.6
Total Assets 38805.9 44981 43908.4 39286.1 46633.1 48806
Property/Plant/Equipment, Total - Net 8252.6 8826.5 7996.1 8405 8681.9 8985.1
Property/Plant/Equipment, Total - Gross 16777.6 18091.1 16663 17566.6 18252.6 18961.8
Accumulated Depreciation, Total -8525 -9264.6 -8666.9 -9161.6 -9570.7 -9976.7
Goodwill, Net 3972.7 4370.1 1366.6 3679.4 3766.5 3892
Intangibles, Net 4357.9 4029.2 1068 6618 7450 7691.9
Long Term Investments 5207.5 5678.8 2005.4 1962.4 2966.8 3212.6
Other Long Term Assets, Total 1913.8 2874.3 10922.7 4911.7 6305.8 6572
Total Current Liabilities 10986.6 14535.9 11888.1 11775.2 12481.6 15052.7
Accounts Payable 1349.3 1410.7 1207.1 1405.3 1606.7 1670.6
Accrued Expenses 896.9 997.9 955.6 915.5 997.2 958.1
Notes Payable/Short Term Debt 1299.3 2696.8 498.9 1494.2 0 0
Current Port. of LT Debt/Capital Leases 638.1 1009.8 603.3 5.1 8.7 1538.3
Other Current Liabilities, Total 6803 8420.7 8623.2 7955.1 9869 10885.7
Total Liabilities 24798.2 33388.8 34079.7 36679.2 40991.5 39826.8
Total Long Term Debt 8367.8 9940.5 9196.4 13817.9 16586.6 15346.4
Long Term Debt 8358.8 9931.8 9196.4 13817.9 16586.6 15346.4
Capital Lease Obligations 9 8.7
Minority Interest 72.8 75.7 1080.4 92.2 183.6 175.6
Other Liabilities, Total 5371 8836.7 10602.1 8806.4 9639.8 7518.4
Total Equity 14007.7 11592.2 9828.7 2606.9 5641.6 8979.2
Common Stock 688.5 687.9 661 598.8 598.2 596.3
Additional Paid-In Capital 5640.6 5817.8 6583.6 6685.3 6778.5 6833.4
Retained Earnings (Accumulated Deficit) 16046.3 13894.1 11395.9 4920.4 7830.2 8958.5
Treasury Stock - Common -80.5 -75.8 -69.4 -60.8 -55.7 -52.7
Unrealized Gain (Loss) 224 113.5 4.9 14.8 3.7
Other Equity, Total -8511.2 -8845.3 -8742.4 -9541.7 -9524.4 -7360
Total Liabilities & Shareholders’ Equity 38805.9 44981 43908.4 39286.1 46633.1 48806
Total Common Shares Outstanding 1100.88 1100.01 1057.64 957.526 956.59 953.653
Other Current Assets, Total 2229.1 0
Deferred Income Tax 1312.7 2187.5 2099.9 1733.7
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Käibevarad kokku 16604.5 17295.5 17808.3 18452.4 16964.7
Raha ja lühiajalised investeeringud 3051.4 3271.2 3825.3 3908.6 2568.3
Raha ja ekvivalendid 3002.4 3220 3788.2 3818.5 2459.2
Lühiajalised investeeringud 49 51.2 37.1 90.1 109.1
Laekumata arved, neto 6658.6 6902.8 7025 8127.2 7805.7
Accounts Receivable - Trade, Net 5592.8 5829.4 5914.3 6672.8 6322.5
Total Inventory 3660.8 3824.9 3907.4 3886 3893
Prepaid Expenses 3233.7 3296.6 3050.6 2530.6 2697.7
Total Assets 46838.3 47809 48187 48806 46919.3
Property/Plant/Equipment, Total - Net 8630.1 8855.5 8920.4 8985.1 9102.7
Property/Plant/Equipment, Total - Gross 18273.5 18697.7 18883.2 18961.8 19241
Accumulated Depreciation, Total -9643.4 -9842.2 -9962.8 -9976.7 -10138.3
Goodwill, Net 3877.4 3884.2 3884.1 3892 3892
Intangibles, Net 8087.8 7985.4 7887.7 7691.9 7482.4
Long Term Investments 3232.4 3474.9 3350.5 3212.6 2727.3
Other Long Term Assets, Total 6406.1 6313.5 6336 6572 6750.2
Total Current Liabilities 11714.2 15093.2 13682 15052.7 13386
Accounts Payable 1639.6 1597.8 1566.8 1670.6 1433.3
Accrued Expenses 649.9 755.5 836.6 958.1 693.1
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 4.9 1778.5 1563 1538.3 1355.9
Other Current Liabilities, Total 9419.8 10961.4 9715.6 10885.7 9903.7
Total Liabilities 39939.6 41364.6 40430 39826.8 37588.5
Total Long Term Debt 16199.6 14736.6 15522.4 15346.4 15152.9
Long Term Debt 16199.6 14736.6 15522.4 15346.4 15152.9
Deferred Income Tax 2200.6 1857.3 1632.5 1733.7 1286.1
Minority Interest 200.6 219.1 197.1 175.6 131.2
Other Liabilities, Total 9624.6 9458.4 9396 7518.4 7632.3
Total Equity 6898.7 6444.4 7757 8979.2 9330.8
Common Stock 599.7 598.1 598.2 596.3 594.1
Additional Paid-In Capital 6579.2 6669.2 6758 6833.4 6656.3
Retained Earnings (Accumulated Deficit) 9181.3 8530.1 9639.4 8958.5 9369.4
Treasury Stock - Common -52.7 -52.7 -52.7 -52.7 -50.5
Unrealized Gain (Loss) 4.5 9.1 6.8 3.7 -18.1
Other Equity, Total -9413.3 -9309.4 -9192.7 -7360 -7220.4
Total Liabilities & Shareholders’ Equity 46838.3 47809 48187 48806 46919.3
Total Common Shares Outstanding 959.019 956.575 956.589 953.653 950.155
  • Aastas
  • Kvartalis
2016 2017 2018 2019 2020 2021
Netotulu/algväärtus 2737.6 -204.1 3232 8318.4 6193.7 5581.7
Raha majandustegevusest 4851 5615.6 5524.5 4836.6 6499.6 7260.7
Raha majandustegevusest 1496.6 1567.3 1609 1232.6 1323.9 1547.6
Deferred Taxes 439.5 -787.9 326.8 62.4 -134.5 -802.3
Mittelikviidsed varad 661.4 1835.4 2735.4 -3089.6 -136.1 1956.3
Cash Taxes Paid 700.6 246.5 1101.5 1180.5 954.6 1598.8
Makstud intressid 146.4 192.7 223.8 305.5 345.8 338
Muutused tööjõus -484.1 3204.9 -2378.7 -1687.2 -747.4 -1022.6
Tulu investeeringutelt -3139.1 -3783.6 1906 -8082.9 -2258.9 -2762.3
Kapitalikulutused -1092 -2163.6 -3018.2 -1353.5 -2029.1 -1873.2
Muud rahavood investeeringutelt, kokku -2047.1 -1620 4924.2 -6729.4 -229.8 -889.1
Rahavood investeeringutelt -559.8 142.6 -5904.9 -2324.5 -3137.1 -4131.3
Rahavoogudesse investeerimine -300.8 -364.4 -372.8 -200.1 -241.6 -295.9
Total Cash Dividends Paid -2158.5 -2192.1 -2311.8 -2409.8 -2687.1 -3086.8
Aktsiate emiteerimine (tagasiost), neto -600.1 -299.8 -2491 -4400 -500 -1250
Laenu väljastamine (kustutamine), neto 2499.6 2998.9 -729.3 4685.4 291.6 501.4
Muutused valuutakursside kõikumisest -236.4 -20.5 -63.6 -89.9 216 -205.7
Rahaline kogumuutus 915.7 1954.1 1462 -5660.7 1319.6 161.4
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line 1355.3 2745.5 3855.6 5581.7 1902.9
Cash From Operating Activities 1697.4 3472.9 5104.2 7260.7 2499.2
Cash From Operating Activities 350.3 719.6 1101.9 1547.6 435.7
Deferred Taxes -119.1 -413.8 -709.8 -802.3 -506.6
Non-Cash Items 213.7 303.2 1404.6 1956.3 712.7
Changes in Working Capital -102.8 118.4 -548.1 -1022.6 -45.5
Cash From Investing Activities -1283.5 -1766.8 -2383.3 -2762.3 -1013.8
Capital Expenditures -492.1 -1023.4 -1479 -1873.2 -857.2
Other Investing Cash Flow Items, Total -791.4 -743.4 -904.3 -889.1 -156.6
Cash From Financing Activities -1058.4 -2141.6 -2604.8 -4131.3 -2878.3
Financing Cash Flow Items -279.9 -294.8 -295.3 -295.9 -282.4
Total Cash Dividends Paid -774.8 -1543.1 -2313.5 -3086.8 -885.5
Issuance (Retirement) of Stock, Net 0 -500 -500 -1250 -1500
Issuance (Retirement) of Debt, Net -3.7 196.3 504 501.4 -210.4
Foreign Exchange Effects -10.2 -1.6 15 -205.7 33.6
Net Change in Cash -654.7 -437.1 131.1 161.4 -1359.3
Investori nimi Investori liik Ringluse protsent Hoitud osakud Muutus osakutes Hoidmise kuupäev Hinnang käibele
Lilly Endowment, Inc. Investment Advisor 10.8347 102948810 -210000 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 7.6008 72221213 994066 2022-09-30 LOW
PNC Wealth Management Investment Advisor 5.4451 51738161 -44061 2022-09-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 4.2364 40253792 58949 2022-09-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 3.5343 33582472 168444 2022-09-30 LOW
Fidelity Management & Research Company LLC Investment Advisor 3.3604 31929656 631015 2022-09-30 LOW
Capital World Investors Investment Advisor 3.0547 29024874 282228 2022-09-30 LOW
PRIMECAP Management Company Investment Advisor 2.9486 28017155 -421333 2022-09-30 LOW
T. Rowe Price Associates, Inc. Investment Advisor 2.5054 23805927 3379269 2022-09-30 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 2.2989 21843288 -1593968 2022-09-30 LOW
State Farm Insurance Companies Insurance Company 1.8324 17410725 0 2022-09-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.6935 16091249 373938 2022-09-30 LOW
Jennison Associates LLC Investment Advisor/Hedge Fund 1.0592 10064742 -293324 2022-09-30 LOW
JP Morgan Asset Management Investment Advisor 0.866 8228610 173535 2022-09-30 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.8435 8014500 -246196 2021-12-31 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.7439 7068030 -132558 2022-09-30 LOW
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.6244 5933104 -307204 2022-09-30 LOW
Capital International Investors Investment Advisor 0.5893 5599174 637189 2022-09-30 LOW
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.5885 5591703 -216451 2022-09-30 LOW
BofA Global Research (US) Research Firm 0.5868 5576096 -144521 2022-09-30 LOW

Miks valida Capital.com? Meie numbrid räägivad iseenda eest.

Capital.com Group
+485000+

Kauplejad

65000+

Igakuiste aktiivsete klientide arv

$48000000+

Igakuine investeerimise maht

$28000000+

Igakuiselt välja võetud

Kauplemiskalkulaator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Kauplemise vahendustasu
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Finantsvõimendus
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investeering
Tehingu suurus (võimendus x investeering):
Avamishind

Close

Lühike Pikk

Eli Lilly Company profile

Ettevõttest Eli Lilly & Co

Eli Lilly and Company on ravimit tootev ettevõte. Ettevõte tegeleb farmaatsiatoodete väljatöötamise, arendamise, tootmise, turustamise ja müügiga kogu maailmas. Ettevõtte diabeeditoodete hulka kuuluvad Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta ja Trulicity. Ettevõtte onkoloogiatoodete hulka kuuluvad Alimta, Cyramza, Erbitux, Retevmo, Tyvyt ja Verzenio. Ettevõtte immunoloogiatoodete hulka kuuluvad Olumiant ja Taltz. Tema neuroteaduslike toodete hulka kuuluvad Cymbalta, Emgality, Reyvow ja Zyprexa. Muude ravimeetodite hulka kuuluvad Bamlanivimab, etesevimab, Cialis ja Forteo. Ettevõte toodab ja turustab oma tooteid Ameerika Ühendriikides, sealhulgas Puerto Ricos, ja veel umbes kaheksas riigis asuvate rajatiste kaudu. Ettevõtte tooteid müüakse ligikaudu 120 riigis. Ettevõtte tütarettevõtete hulka kuuluvad muu hulgas Acanthas Pharma, Inc., Alnara Pharmaceuticals, Inc., ARMO Biosciences, Inc. ja Avid Radiopharmaceuticals, Inc.

Industry: Pharmaceuticals (NEC)

Lilly Corporate Ctr
Drop Code 1094
INDIANAPOLIS
INDIANA 46285-0001
US

Tuluaruanne

  • Annual
  • Quarterly

Teised on vaadanud veel

US100

12,566.80 Price
-0.450% 1D Chg, %
Pika positsiooni ööpäeva tasu -0.0183%
Lühikese positsiooni ööpäeva tasu 0.0071%
Ööpäeva tasu aeg 22:00 (UTC)
Hinnavahe 3.0

Natural Gas

2.41 Price
-2.390% 1D Chg, %
Pika positsiooni ööpäeva tasu -0.1138%
Lühikese positsiooni ööpäeva tasu 0.0796%
Ööpäeva tasu aeg 22:00 (UTC)
Hinnavahe 0.005

Oil - Crude

73.41 Price
-3.570% 1D Chg, %
Pika positsiooni ööpäeva tasu -0.0223%
Lühikese positsiooni ööpäeva tasu 0.0065%
Ööpäeva tasu aeg 22:00 (UTC)
Hinnavahe 0.03

XRP/USD

0.40 Price
-3.910% 1D Chg, %
Pika positsiooni ööpäeva tasu -0.0500%
Lühikese positsiooni ööpäeva tasu 0.0140%
Ööpäeva tasu aeg 22:00 (UTC)
Hinnavahe 0.00323

Kas otsite jätkuvalt vahendajat, keda saab usaldada?

Ühinege 485,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com

1. Looge ja kinnitage oma konto 2. Tee sissemakse 3. Alusta kauplemist